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We had previously reported the cloning of the complete genome of an isolate of hepatitis C virus (HCV), HCV-S1, of
genotype 1b. We have constructed a full-length complementary DNA (cDNA) clone of HCV-S1 using nine overlapping cDNA
clones that encompassed its entire genome. HCV core, E1, E2, NS-3, -4B, -5A, and -5B proteins were detected in 293T cells
by immunoblot analyses when expression of the full-length HCV-S1 was driven under a CMV promoter. Expression of
full-length HCV-S1 led to induction of the CC chemokines RANTES and MCP-1 at both the mRNA and the protein levels in
HeLa, Huh7, and HepG2 cells. Reporter gene assays showed that a minimal MCP-1 promoter construct containing 128
nucleotides upstream of its translational start site was sufficient for optimal HCV-mediated activation. HCV induced AP-1
binding activities to this region, as determined from electrophoretic mobility shift assays and supershifts with anti-AP-1
antibodies. Transfection of full-length HCV-S1 up-regulated both AP-1 binding activities as well as c-jun transcripts. A minimal
promoter construct containing 181 nucleotides upstream of the RANTES translational start site was sufficient for maximal
HCV-mediated induction. Gel mobility shift and supershift assays showed that HCV induced NF-B and other unknown
binding activities to the A/B-site within this region. In HeLa cells, HCV core and NS5A could separately augment promoter
activities of both MCP-1 and RANTES. In Huh7 cells, only NS5A produced a similar effect, while rather surprisingly, HCV core
induced a dramatic reduction in promoter activities of these two genes. This study provides the first direct evidence for the
induction of CC chemokines in HCV infection and draws attention to their roles in affecting the progress and outcome ofINTRODUCTION
Hepatitis C virus (HCV) is a member of the Flaviviridae
family, and the major cause of chronic liver disease
worldwide (Alter et al., 1989; Houghton et al., 1991). HCV
is an enveloped virus with a single-stranded, positive-
sense, nonsegmented RNA genome that encodes a sin-
gle open reading frame (ORF) of 3010 amino acids
(aa), which is cotranslationally and posttranslationally
cleaved to give at least 10 polypeptides (Choo et al.,
1991). Located at its N-terminal end are three structural
proteins, followed by at least seven nonstructural (NS)
proteins (Choo et al., 1991). These proteins are pro-
cessed by a host-derived signalase and cleaved by vi-
rus-encoded proteases (Harada et al., 1991; Hijikata et
al., 1991; Matsura et al., 1992; Selby et al., 1993; Tomei et
al., 1993).
Similar to other RNA viruses, the genome of HCV is
highly heterogeneous, and several genotypes and sub-
types have been described (Lanford et al., 1994; Ito et al.,1996). Numerous studies have successfully demon-
strated partial replication of the virus in in vitro culture
systems using human T and B cells (Bertolini et al., 1993;
Shimizu et al., 1993) and hepatocytes of human (Iaco-
vacci et al., 1993; Ito et al., 1996; Ikeda et al., 1998) or
chimpanzee origin (Lanford et al., 1994). However, these
systems suffer from low viral replication efficiency and
limited passage cycles. More recently, high-level repli-
cation of subgenomic HCV RNAs was established in a
human hepatoma cell line that would enable long-term
production of viral RNAs and proteins (Lohmann et al.,
1999; Blight et al., 2000).
Thus the steps taken to construct a full-length HCV
clone are of paramount importance in determining its
replication-competence and infectivity. Nucleotide se-
quences have been reported for at least 42 HCV ge-
nomes from around the world. However, several of these
sequences were derived from pooled plasma samples of
HCV-infected patients, with only one or two obtained
from infected individuals (Aizaki et al., 1998). To this end,
we have taken the path toward creating a replication-HCV-associated liver diseases. © 2002 Elsevier Science (USA)
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carrier who was chronically infected with HCV (Lim et al.,
2001). We report here that this full-length HCV genome
expressed its structural and nonstructural proteins when
transfected into cell lines.
RANTES (regulated upon activation, normal T cell ex-
pressed and secreted) and monocyte chemoattractant
protein 1 (MCP-1) are members of the CC chemokine
family. MCP-1 is known to play a significant role in
monocyte infiltration to sites of injury and inflammation
(Leonard and Yoshmura, 1990; Schall et al., 1990), while
RANTES has chemotactic properties for numerous cell
types, including T lymphocytes, monocytes (Schall et al.,
1990), and NK cells (Taub et al., 1995). In addition, both
chemokines have been shown to be induced by some
viruses in a wide variety of cells after infection (Mati-
kainen et al., 2000; Gupta et al., 2001; Haeberle et al.,
2001; Peterson et al., 2001), including members of the
flavivirus family. Induction of RANTES was observed in
dengue-2 virus-infected liver cells (Lin et al., 2000) and
both RANTES and MCP-1 were induced during Japanese
encephalitis virus infection of astrocytes (Chen et al.,
2000). Such a cellular response in vivo can serve to
recruit lymphocytes and stimulate the host immune re-
sponse to viral infections. Production of chemokines in
the liver is likely to play a role in HCV infection, as
infiltration of lymphocytes has been observed in concom-
itance with chronic disease (Minutello et al., 1993; Ze-
hender et al., 1997; Sansonno et al., 1998; Crispe et al.,
2000). In this study we demonstrate that hepatitis C virus
is capable of inducing MCP-1 and RANTES gene expres-
sions in both nonhepatic and hepatic cell lines. Using
cotransfection experiments with the full-length HCV
cDNA, HCV-S1, we determined that the induction is ini-
tiated at the transcriptional level via activation of the
transcriptional factor AP-1 in the case of MCP-1 induc-
tion, and via NF-B and other unknown factors in RAN-
TES. These findings have important implications in our
understanding of HCV-associated liver pathogenesis.
RESULTS
Construction and characterization of expression
constructs for the full-length HCV genome, HCV-S1
Nine overlapping cDNAs clones covering the entire
HCV genome were obtained by RT-PCR from sera de-
rived from a chronic HCV carrier (Lim et al., 2001). These
were assembled together in stepwise ligations as de-
scribed under Materials and Methods. Resultant clones
FIG. 1. Expression of HCV structural and nonstructural proteins (A–G) in 293T cells transiently transfected with a full-length (FL) HCV expression
construct, pXJ(S1). Cells were harvested at 2 and 4 days posttransfection. Untransfected cells were used as controls (Day 0). Cells were lysed and
resolved on 12% SDS–PAGE gels and subjected to immunoblot analyses with the various antibodies as described under Materials and Methods.
Arrows indicate the respective HCV proteins. Molecular masses in kilodaltons (kDa) of protein molecular weight markers are indicated on the left.
Levels of HCV protein expressed were normalized against endogenous actin levels (H).
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comprising the region from the 5UTR to NS2 (nt 341 to
2461) were first functionally tested by in vitro coupled
transcription-translation to ensure that all the HCV struc-
tural proteins could be properly translated (data not
shown). Clones comprising the region from the NS2-3
UTR (nt 2428–9268) were similarly analyzed (data not
shown). The full-length (FL) HCV genome was assem-
bled from these clones to generate the expression con-
structs pcDNA3(S1) and pXJ41(S1). To characterize this
full-length clone, we transiently transfected pXJ(S1) into
293T cells and examined the expression of HCV proteins
by Western analyses. We were able to detect HCV struc-
tural (core, E1, and E2) and nonstructural (NS-3, -4B, -5A,
and -5B) proteins at 2 and 4 days posttransfection (Figs.
1A–1G). Thus, the FL HCV genome could be properly
transcribed and translated to yield the complete polypro-
tein which in turn could be processed to the individual
proteins. Transfection with the expression construct
pcDNA3(S1) produced similar results, although lower
HCV protein levels were observed (data not shown).
Induction of CC chemokines RANTES and MCP-1 in
HCV-S1-transfected cells
Recently, a member of the flavivirus, dengue-2 virus,
was shown to induce the expression of CC chemokine
RANTES upon infecting liver cells (Lin et al., 2000). It has
also been reported by several groups that infection of
some viruses leads to cellular induction of chemokines
(Matikainen et al., 2000; Gupta et al., 2001; Haeberle et
al., 2001; Peterson et al., 2001). This phenomenon could
conceivably play an important role in determining the
final outcome of the disease(s) manifested in infected
individuals. We therefore set out to determine if HCV
FIG. 2. (A) RT-PCR of MCP-1 (lanes 1–3) and RANTES (lanes 4–6) transcripts in (i) HeLa, (ii) Huh7, and (iii) HepG2 cells transfected with pXJ(S1)
at 2 (lanes 2, 5, and 8) and 3 days (lanes 3, 6, and 9) posttransfection. As a control, cells were transfected with vector pXJ41neo for 2 days (lanes 1,
4, and 7). RT-PCR was performed on total cellular RNA extracted from cells as described under Materials and Methods (see also Table 1). Levels of
endogenous actin mRNA (lanes 7–9) are shown. M indicates 100-bp DNA ladder. Asterisk indicates nonspecific bands. (B) Semiquantitative detection
of (i) RANTES, and (ii) MCP-1 mRNA in HepG2 cells by RT-PCR. Cells were transfected with pXJ(S1) for 2 (lanes 2, 5, 8, 11, and 14) and 3 days (lanes
3, 6, 9, 12, and 15) or with vector pXJ41neo for 2 days (lanes 1, 4, 7, 10, and 13). Serial dilutions of cDNA samples (1:2, 1:4, 1:8, and 1:16, depicted as
2, 4, 8, and 16) were prepared and subjected to PCR as in (A). Levels of endogenous actin mRNA (iii) are shown.
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would similarly induce the expression of RANTES or
MCP-1. Using specific primers, we performed RT-PCR for
these chemokines, with total cellular RNA collected from
cells at 2 and 3 days posttransfection with pXJ(S1). As a
control, we used RNA from cells transfected with the
vector pXJ41neo. We found strong inductions of both
RANTES and MCP-1 transcripts in the epithelial cell line,
HeLa, as well as in the hepatoma cell lines, Huh7 and
HepG2 (Fig. 2A). In addition, we observed that induction
of RANTES mRNA appeared to be more tightly regulated
as its levels began to decline by day 3 posttransfection in
two of the three cell lines (HeLa and Huh7). In contrast,
induction of MCP-1 transcripts appeared to be either
sustained (in HeLa and Huh7) or increased (in HepG2) at
3 days after transfection (Fig. 2A). We next performed a
semiquantitative PCR analyses for RANTES and MCP-1
expression in HepG2 cells using serial dilutions of the
cDNA samples. We observed that HCV-mediated induc-
tion of both MCP-1 and RANTES was associated with an
at least 16-fold increase over basal transcripts levels 3
days after expression of HCV proteins in HepG2 cells
(Fig. 2B). Furthermore, we detected increased levels of
RANTES and MCP-1 proteins in pXJ(S1)-transfected cells
by FACscan analysis using intracellular staining with
specific antibodies to these chemokines (Fig. 3). Three
days after transfection with the HCV genome, intracellu-
lar levels of RANTES protein in HeLa cells were higher
than those of cells transfected with the vector pXJ41neo
(Figs. 3A and 3B). In addition, intracellular MCP-1 levels
were also increased (Figs. 3C and 3D). A similar trend
was also observed in HCV-transfected Huh7 (Figs. 3E–
3H) and HepG2 cells (Figs. 3I–3L). Expression of FL HCV
therefore induces the expression of the chemokines in
both hepatic and nonhepatic cell lines.
HCV genome activates promoters of RANTES and
MCP-1
To further investigate the activation of MCP-1 and
RANTES by FL HCV at the transcriptional level, we car-
ried out transient cotransfection experiments with
pXJ(S1) and 5 deletion promoter constructs of MCP-1
(Lim and Garzino-Demo, 2000) and RANTES (Nelson et
al., 1993, 1996). We found that FL HCV significantly stim-
ulated luciferase activities of deletion promoter con-
structs of both these genes in HeLa and Huh7 cells (Fig.
4). In the case of MCP-1, the construct, phMCP213, bear-
ing a 213 base pair (bp) of the MCP-1 promoter was
induced by 3.6-fold over basal levels in HeLa cells, while
the activity of phMCP128, containing a 128-bp fragment,
was increased by 2.4-fold at 48 h posttransfection (Fig.
4A). When the experiments were repeated in Huh7 cells,
the activities of these constructs were found to be aug-
mented by 2.9- and 2-fold, respectively, above basal
levels (Fig. 4B). These results suggest that the region
comprising 128 bp upstream from the translational start
site of MCP-1 contained sufficient binding elements to
enable the gene to be optimally activated by HCV, al-
though additional binding elements within the region
from nt 128 to nt 213 could also participate to augment
gene activation. Thus it appears that the AP-1 and NF-B
sites located at positions 150 and 137, respectively,
are less important in HCV-mediated MCP-1 induction
than downstream binding motifs such as the SP-1 (at
115), NF-1 (at70), and the second AP-1 site (at122).
FIG. 3. FACscan analyses of HeLa (A–D), Huh7 (E–H), and HepG2
(I–L) cells transfected with vector, pXJ41neo (A, C, E, G, I, and K), or
full-length (FL) HCV construct, pXJ(S1) (B, D, F, H, J, and L) at 3 days
posttransfection. Intracellular staining was carried out with PE-conju-
gated antibodies specific for MCP-1 (C, D, G, H, K, and L) or RANTES
(A, B, E, F, I, and J) as described under Materials and Methods. Solid
line (—) denotes unstained cells; dotted line (- -) denotes cells stained
with specific antibodies, and bold solid line ( ) denotes the final
fluorescence after subtracting the first (background) from the second.
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We next examined the effect of HCV on the activities of
deletion constructs for the RANTES promoter. The con-
struct, phR961, which bears a 961 bp of its promoter
sequence, was induced by 2.9-fold over basal levels in
HeLa cells, while phR181, which contains a 181-nt se-
quence immediately upstream of the promoter, was in-
creased by 2.8-fold (Fig. 4C). In Huh7 cells, their activities
were also comparable; the former was stimulated by
FIG. 4. Deletion analysis of the HCV-mediated up-regulation of 5 flanking regions of MCP-1 and RANTES. Luciferase assays were performed with
extracts of HeLa cells (A and C) and Huh7 (B and D) cells transfected with different 5 deletion constructs for MCP-1 (A and B) or RANTES (C and
D), at 48 h posttransfection. Results are expressed as the absolute luciferase activity in each cell extract and were normalized according to units of
renilla luciferase activity from cotransfection with a pTK-renilla luciferase construct and total protein content. Data shown are the means (SD) of
three independent transfection experiments.
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FIG. 5. HCV enhanced binding of transcriptional factors to MCP-1 promoter region. (A) A radiolabeled DNA fragment containing from 128 to 6
bp from the hMCP-1 5 flanking region was incubated with nuclear extracts from vector-transfected (lane 1) or pXJ(S1)-transfected (lane 2) Huh7 cells.
Arrows indicate specific DNA–protein complexes. (B) Lanes 1–8 represent EMSAs with nuclear extracts from vector-transfected Huh7 cells, while
lanes 9–16 represent EMSAs with nuclear extracts from pXJ(S1)-HCV-transfected Huh7 cells. Competition assays were performed with 100-fold molar
excess of unlabeled DNA fragments corresponding to the 128 to 6 hMCP-1 5 flanking region (lanes 2 and 10) or 100-fold molar excess of
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3.8-fold above control cells and the latter was stimulated
by 3.2-fold above control cells (Fig. 4D). Thus, it appears
that the minimal construct containing 181 bp of the RAN-
TES promoter region was sufficient for maximal gene
activation by HCV. Interestingly, this suggests that tran-
scriptional binding elements upstream of this minimal
region, such as the three AP-1 sites at 402, 420, and
429 (Nelson et al., 1993), do not participate in HCV-
mediated induction of RANTES.
HCV genome induces AP-1 binding activities at
minimal hMCP-1 promoter region, hMCP128
The 128-nt upstream region of the MCP-1 promoter
contains putative cis-acting elements for AP-1 (122),
SP-1 (115), NF-1 (70), and CAAT (33) (Shyy et al.,
1993; Li and Kolattukudy, 1994; Lim and Garzino-Demo,
2000). To explore the roles of these various cis-acting
elements in the HCV-mediated up-regulation of the
MCP-1 gene, we conducted electrophoretic mobility shift
assays (EMSAs) with this region of the gene as probe.
Nuclear extracts prepared from vector-transfected Huh7
cells produced two distinct DNA–protein complexes
when shifted with a radiolabeled DNA fragment corre-
sponding to region 128 to 6 of the hMCP promoter
(hMCP128; Fig. 5A, lane 1, bands b and c). Binding of
both complexes was completely competed out by excess
unlabeled probe, as well as by excess unlabeled oligo-
nucleotides with a consensus SP1-binding motif (Fig. 5B,
lanes 2 and 3). In addition, they were partially competed
out by excess unlabeled oligonucleotides containing the
NF-1 binding sequences (Fig. 5B, lane 7). In contrast,
excess unlabeled oligonucleotides bearing consensus
AP1-binding motifs, as well as oligonucleotides with mu-
tated SP-1, AP-1 and NF-1 sites, failed to abolish the
DNA–protein complexes (Fig. 5B, lanes 4, 6, and 8).
Interestingly, when we repeated the EMSAs with nu-
clear extracts prepared from FL-HCV-transfected Huh7
cells, we observed the formation of a new complex of
higher mobility (Fig. 5A, lane 2, band a), in addition to the
two DNA–protein complexes (bands b and c) previously
observed in the untransfected cells. Binding of com-
plexes a, b, and c were disrupted by excess unlabeled
probe, and also by excess cold SP-1 (Fig. 5B, lanes 10
and 11) and partially by NF-1 oligonucleotides (Fig. 5B,
lane 15). Notably, the binding of complex a was abol-
ished by excess cold AP-1 oligonucleotides (Fig. 5B, lane
13). Similar to gel-shift assays performed with vector-
transfected cells, oligonucleotides with mutated SP-1,
AP-1, and NF-1 sites failed to abolish any interaction
between hMCP128 and the nuclear complexes (Fig. 5B,
lanes 12, 14, and 16). Hence the results from the EMSAs
with hMCP128 provide strong evidence for the HCV-
mediated induction of AP-1 binding activities on the
MCP-1 promoter.
To determine the specificity of interaction between the
DNA-binding complexes and hMCP128, we conducted
supershift assays with antibodies against SP-1, AP-1, and
p50. With extracts prepared from vector-transfected
cells, complex b was specifically supershifted by SP-1
antibodies (Fig. 5C, lane 3, supershift is denoted by
arrow) but not by AP-1 or p50 antibodies (Fig. 5C, lanes
4 and 5). With extracts prepared from HCV-transfected
cells, complex b was specifically supershifted by SP-1
antibodies (Fig. 5C, lane 6, supershift is denoted by
arrow), while all three complexes a–c were supershifted
by AP-1 antibodies (Fig. 5C, lane 7, supershift is denoted
by arrow). Anti-p50 antibodies failed to induce any su-
pershift in the complexes (Fig. 5C, lane 8). These results
confirm that while SP-1 was involved in the constitutive
regulation of MCP-1, HCV induced the binding of AP-1,
which cooperated with SP-1 in the HCV-mediated up-
regulation of MCP-1.
To further investigate if AP-1 is capable of binding to
the AP-1 site in the minimal MCP-1 promoter sequence,
we conducted gel shifts using recombinant AP-1 (rAP-1)
with hMCP128. We observed the formation of two DNA-
binding complexes, band a and b, following the incuba-
tion of rAP-1 with hMCP128 (Fig. 5D). These two com-
plexes were completely inhibited by addition of excess
cold hMCP128 (Fig. 5D, lane 2) or double-stranded AP-1
oligonucleotides (Fig. 5D, lane 4). In contrast, they were
poorly inhibited by competition with excess cold mutated
AP-1 oligonucleotides (Fig. 5D, lane 5) and cold oligonu-
cleotides corresponding to the A/B site in hRAN181 (Fig.
5D, lane 6).
HCV genome enhances binding activities to A/B site
on the minimal hRANTES promoter region, hRAN181
In the 181-nt upstream region of the RANTES promoter,
putative binding domains for NF-B (102), C/EBP
(119), AP-3 (119), CCAAT (142), and NF IL-6 (164)
have been identified (Nelson et al., 1993). We performed
similar experiments using a radiolabeled DNA fragment
corresponding to this region of the RANTES promoter
unlabeled specific oligonucleotides (lanes 3–8 and 11–16) as indicated. (C) EMSAs supershifts performed with nuclear extracts from vector-
transfected Huh7 cells (lanes 2–5), or pXJ(S1)-HCV-transfected Huh7 cells (lanes 6–10), using specific antibodies against SP-1 (lanes 3 and 8), AP-1
(lanes 4 and 9), and p50 (lanes 5 and 10). Lane 1 consists of free probe. Arrow denotes supershifted complex. (D) EMSAs performed with recombinant
AP-1 proteins and the128 to6 hMCP-1 5 flanking region (lanes 2–6). Competition assays were performed with 100-fold molar excess of unlabeled
DNA fragments corresponding to the 128 to 6 hMCP-1 5 flanking region (lane 3), the A/B site in the minimal RANTES promoter sequence (lane
6) or 100-fold molar excess of unlabeled specific AP-1 (lane 4) and mutated AP-1 oligonucleotides (lane 5). Lane 1 consists of free probe. Arrows
indicate specific DNA–protein complexes.
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(hRAN181; Fig. 6). Nuclear extracts prepared from vector-
transfected Huh7 cells produced two DNA–protein com-
plexes of very similar mobility (Fig. 6A, lane 1, bands a
and b), while transfection with FL HCV in Huh7 cells led
to an overall increase in DNA-binding activities of both
complexes (Fig. 6A, lane 2). Binding of these complexes
was completely competed out by excess unlabeled
probe (Fig. 6B, lanes 2 and 9). Interestingly, binding of
complexes a and b in untransfected cells was success-
fully disrupted by excess unlabeled oligonucleotides
with the A/B site (nt 131 to 103) (Fig. 6B, lane 3),
which contains a sequence homologous to the B-bind-
ing motif. Competition was thus carried out with oligo-
nucleotides bearing consensus NF-B sites. These too
competed out both the DNA–complex formations (Fig.
6B, lane 4), indicating that B-binding factors were in-
volved in constitutive RANTES expression.
Similarly, in the HCV-transfected cells, unlabeled A/B
site and NF-B oligonucleotides inhibited formations of
the complexes (Fig. 6B, lanes 10 and 11). The effect of
competition with A/B site oligonucleotides was more
pronounced than with NF-B oligonucleotides, suggest-
ing that FL HCV induced the binding of other factors
besides members of the NF-B/Rel family to this site. On
the other hand, excess unlabeled NF-IL6 oligonucleo-
tides failed to disrupt any DNA–protein complex forma-
tion in extracts prepared from both untransfected and
transfected cells (Fig. 6B, lanes 6 and 13), implying that
NF-IL6 does not play a significant role in HCV-mediated
induction of RANTES gene expression. Oligonucleotides
with mutated NF-B and NF-IL6 sites also failed to com-
pete out binding of DNA–protein complexes (Fig. 6B,
lanes 5, 7, 12, and 14). Hence, the results from these
EMSA experiments suggest that HCV-induced binding
activities to the A/B site on hRAN181 are important in
mediating the up-regulation of the RANTES gene. To
ascertain this, we performed further gel-shift assays,
using the A/B sequence as a probe. Indeed, transfection
of Huh7 cells with the FL HCV genome led to a marked
increase in A/B binding activities, compared to control
vector-transfected cells (Fig. 7A, compare lanes 1 and 2).
Three DNA–protein complexes were observed (bands a,
b, and c) of which the complex of lowest mobility (band
a) was most strongly induced by HCV (Fig. 7A). The
DNA–protein complexes were specifically disrupted by
excess unlabeled A/B oligonucleotides (Fig. 7B, lanes 2
and 6). Similar to our previous observation on the
181-bp region, A/B binding activities were only partially
disrupted by excess unlabeled NF-B oligonucleotides
(Fig. 7B, lanes 3 and 7), confirming that HCV induced
other factors that bind to this site which may play a role
in enhancing RANTES gene expression. Interestingly,
mutated NF-B oligonucleotides also marginally com-
peted out binding at the A/B site (Fig. 7B, lanes 4 and 8).
The reason for this is unknown, but, it is possible that
other A/B binding proteins could still interact with the
GC-rich region within this sequence.
To confirm that NF-B is involved in binding to
hRAN181 and A/B sequences, we further carried out
supershift assays with p50 and p65 antibodies. Both
antibodies supershifted DNA complexes a and b in nu-
clear extracts prepared from vector- and HCV-trans-
fected cells in gel shifts performed with hRAN181 (Fig.
6C, lanes 3, 4, 7, and 8; supershifts are denoted by arrow)
as probe. When the A/B sequence was used as a probe,
the antibodies mainly supershifted DNA complex a (Fig.
7C, lanes 3, 4, 7, and 8; supershifts are denoted by
arrow). The control antibodies against AP-1 failed to
induce any supershift in extracts prepared from vector-
(Figs. 6C and 7C, lane 5) or HCV- (Figs. 6C and 7C, lane
9) transfected cells. Furthermore, when recombinant p50
proteins were incubated with the A/B sequence, two
complexes, consisting of a major band a and a minor
band b, were observed (Fig. 7D, lane 2). Formation of
both bands was completely abolished by competition
with excess cold oligonucleotides corresponding to the
A/B sequence (Fig. 7D, lane 3) and cold NF-B double-
stranded oligonucleotides (Fig. 7D, lane 4). On the other
hand, these complexes were not competed out by ex-
cess cold mutated NF-B oligonucleotides (Fig. 7D, lane
5) or cold hMCP128 element (Fig. 7D, lane 6).
Full-length HCV up-regulates AP-1 and NF-B
activities
Based on our transfection experiments and EMSAs,
AP-1 appears to play an important role in FL HCV-medi-
ated induction of MCP-1, and NF-B is involved in the
induction of RANTES. To confirm that the FL HCV ge-
nome which we have constructed is indeed able to
induce these two transcriptional factors, we carried out
additional cotransfection experiments with pXJ(S1) and
luciferase reporter constructs containing consensus
binding elements for AP-1 or NF-B. Two days posttrans-
fection, AP-1-driven luciferase activities in HeLa cells
transfected with FL HCV were 3.2-fold above those of
cells transfected with vector alone (Fig. 8A). This level of
induction was comparable to that for NF-B-driven lucif-
erase activities which were increased by 2.9-fold over
the same period in the same cell line (Fig. 8B). Similarly,
both AP-1 and NF-B induced activities were enhanced
by 3.3- and 3.4-fold, respectively, in FL HCV-transfected
Huh7 (Figs. 8C and 8D). These results confirmed the
ability of the FL HCV to induce both trans-activating
factors and suggest that these proteins have different
trans-activating effects on different CC chemokine
genes. We hypothesize that while AP-1 binding proteins
are involved in FL HCV-mediated induction of MCP-1,
they are not important for HCV-mediated induction of
RANTES. Conversely, NF-B binding activities do not
play a significant role in the FL HCV-mediated up-regu-
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FIG. 6. HCV enhanced binding of transcriptional factors to RANTES promoter region. (A) A radiolabeled DNA fragment containing from 181 to 6
bp from the hRANTES 5 flanking region was incubated with nuclear extracts from vector-transfected (lane 1) or pXJ(S1)-transfected (lane 2) Huh7
cells. Arrows indicate specific DNA–protein complexes. (B) Lanes 1–7 represent EMSAs with nuclear extracts from vector-transfected Huh7 cells,
while lanes 8–14 represent EMSAs with nuclear extracts from pXJ(S1)-transfected Huh7 cells. Competition assays were performed with 100-fold molar
excess of unlabeled DNA fragments corresponding to the 181 to 6 hRANTES 5 flanking region (lanes 2 and 9) or 100-fold molar excess of
unlabeled specific oligonucleotides (lanes 3–7 and 10–14) as indicated. (C) EMSAs supershift assays performed with nuclear extracts from
vector-transfected Huh7 cells (lanes 2–5), or pXJ(S1)-transfected Huh7 cells (lanes 6–9), using specific antibodies against p50 (lanes 3 and 7), p65
(lanes 4 and 8), and AP-1 (lane 5 and 9). Lane 1 consists of free probe. Arrow denotes supershifted complex.
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lation of MCP-1 expression, but they cooperate with
unknown factors during HCV-mediated up-regulation of
RANTES expression.
HCV proteins differentially activate NF-B and
RANTES promoter in HeLa and Huh7 cells
Results from the gel-shift and luciferase reporter as-
says indicated that binding of NF-B to the RANTES
promoter was induced upon expression of HCV proteins.
To further investigate the particular HCV protein(s) that
was responsible for the induction of NF-B, we carried
out further transfection experiments using expression
constructs for various HCV proteins. The induction levels
are summarized in Table 1. In HeLa cells, both core and
NS5A up-regulated the activity of the NF-B luciferase
reporter construct (Fig. 9A, Table 1). Transfection of core
markedly increased the NF-B activities by 11.4-fold over
the basal levels (Fig. 9A, Table 1). Transfection with
either NS5A or the full-length HCV construct led to a
more moderate increase of 2.6-fold over basal levels
(Fig. 9A, Table 1). A construct bearing all the nonstruc-
tural HCV proteins (NSP) gave a comparable increase as
NS5A and the full-length genome (2.9-fold above basal
levels), suggesting that other nonstructural proteins do
not enhance NF-B activities (Fig. 9A, Table 1). Also a
construct bearing all the structural proteins (SP) failed to
induce any NF-B activities (Fig. 9A, Table 1), suggesting
that the structural proteins E1 and E2 did not activate
NF-B and may instead inhibit the activity of core.
We then examined at the effects of HCV proteins on
the minimal RANTES promoter construct, phR181 in
HeLa cells. We observed that core and NS5A induced
RANTES promoter activities by 5.2- and 2.8-fold, respec-
tively, over basal levels (Fig. 9B, Table 1). This was
comparable to the levels induced by the NSP and the
full-length HCV constructs, which increased its activities
by 3.9- and 5.6-fold, respectively (Fig. 9B, Table 1). The
SP construct produced a smaller increase of twofold (Fig.
9B, Table 1), suggesting again that other structural pro-
teins may inhibit core activity on the RANTES promoter.
Thus, in HeLa cells activation of NF-B and RANTES
promoter activities appear to be mediated mainly by core
and NS5A.
We then repeated these experiments with the reporter
constructs for NF-B and the RANTES promoter in the
human hepatoma cell line, Huh7. Similar to the observa-
tion in HeLa cells, NS5A, NSP, and full-length HCV ge-
nome increased the activity of the NF-B luciferase re-
porter construct to comparable levels of 2.4-, 3.2-, and
3.1-fold, respectively (Fig. 9C, Table 1). Transfection of SP
construct again failed to induce NF-B activities (Fig. 9C,
Table 1). Rather surprisingly, in contrast to the observa-
tion in HeLa cells, core strongly reduced NF-B activities
in Huh7 cells. The levels were decreased by 58% com-
pared to the basal levels (Fig. 9C, Table 1). We then
proceeded to study the effect of these various HCV
proteins on the RANTES promoter construct, phR181, in
Huh7 cells. Similar to our findings on the NF-B con-
struct, core also significantly suppressed RANTES pro-
moter activity by 70% (Fig. 9D, Table 1), while NS5A, NSP,
and full-length HCV genome constructs increased its
activity by 2.7-, 6.8-, and 6.8-fold, respectively (Fig. 9D,
Table 1). Similar to in HeLa cells, the SP construct in-
duced RANTES promoter activity by twofold (Fig. 9D,
Table 1). Therefore, in Huh7 cells induction of NF-B and
RANTES promoter activities appears not to be mediated
by core, but by NS5A. In addition, in Huh7 cells, other
nonstructural protein(s) may activate RANTES via an
NF-B independent mechanism. Finally, in Huh7 cells,
HCV structure proteins E1 and E2 could weakly activate
the RANTES promoter by a mechanism that also may not
involve NF-B.
HCV proteins differentially activate AP-1 and MCP-1
promoter in HeLa and Huh7 cells
Results from the gel-shift and reporter transfection
assays indicated that binding of AP-1 to the MCP-1
promoter was induced upon expression of HCV proteins.
To ascertain if HCV core, NS5A, and/or other HCV pro-
teins induced the expression of AP-1, we again carried
transfection experiments using expression constructs for
these proteins. In HeLa cells, core up-regulated the ac-
tivity of the AP-1 reporter construct by threefold above
basal levels (Fig. 10A, Table 1). As was observed previ-
ously for the NF-B construct, the SP construct failed to
induce any AP-1 activities (Fig. 10A, Table 1). This also
FIG. 7. HCV enhanced binding of transcriptional factors to A/B site in the RANTES promoter region. (A) A radiolabeled double-stranded
oligonucleotide containing A/B site of the hRANTES 5 flanking region was incubated with nuclear extracts from vector- (lane 1) or pXJ(S1)-transfected
(lane 2) Huh7 cells. Arrows indicate specific DNA–protein complexes. (B) Lanes 1–4 represent EMSAs with nuclear extracts from vector-transfected
Huh7 cells, while lanes 5–8 represent EMSAs with nuclear extracts from pXJ(S1)-transfected Huh7 cells. Competition assays were performed with
100-fold molar excess of double-stranded unlabeled oligonucleotides corresponding to A/B site (lanes 2 and 6) or 100-fold molar excess of unlabeled
specific oligonucleotides (lanes 3–4 and 7–8) as indicated. (C) EMSAs supershift assays performed with nuclear extracts from vector-transfected
Huh7 cells (lanes 2–5), or pXJ(S1)-transfected Huh7 cells (lanes 6–9), using specific antibodies against p50 (lanes 3 and 7), p65 (lanes 4 and 8), and
AP-1 (lane 5 and 9). Lane 1 consists of free probe. Arrow denotes supershifted complex. (D) EMSAs performed with recombinant p50 proteins and
radiolabeled double-stranded oligonucleotides containing A/B site of the hRANTES 5 flanking region (lanes 2–6). Competition assays were performed
with 100-fold molar excess of unlabeled oligonucleotides corresponding to the A/B site in hRANTES promoter (lane 3), NF-B (lane 4), and mutated
NF-B (lane 5) and excess unlabeled DNA fragments corresponding to the 128 to 6 of the 5 flanking region of hMCP128. Lane 1 consists of free
probe. Arrows indicate specific DNA–protein complexes.
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FIG. 8. HCV-mediated up-regulation AP-1 and NF-B activities. Luciferase assays were performed with extracts of HeLa cells (A and B) and Huh7
(C and D) cells cotransfected with reporter constructs for AP-1 (A and C) or NF-B (B and D) and the full-length (FL) HCV expression construct, pXJ(S1),
at 48 h posttransfection. Results are expressed as the absolute luciferase activity in each cell extract and were normalized according to units of renilla
luciferase activity from cotransfection with a pTK-renilla luciferase construct and total protein content. Data shown are the means (SD) of three
independent transfection experiments.
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FIG. 9. Effect of various HCV proteins on the activities of the NF-B and minimal RANTES promoter reporter constructs. Luciferase assays were
performed with extracts of HeLa cells (A and B) and Huh7 (C and D) cells cotransfected with reporter constructs for NF-B (A and C) or RANTES
promoter, phR181 (B and D), and the various expression constructs for HCV proteins, at 35 h posttransfection. Transfection was performed with the
empty vector, pXJ41neo, to determine basal luciferase levels. SP, NSP, and FL HCV denote expression constructs for HCV structural proteins,
nonstructural proteins, and full-length HCV genome, respectively. Results are expressed as the absolute luciferase activity in each cell extract and
were normalized according to total protein content. Data shown are the means (SD) of three to five independent transfection experiments.
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implies that the structural proteins E1 and E2 did not
activate AP-1 and could suppress the activity of core. The
NSP and NS5A constructs both induced AP-1 activities
by 2.5- and 3.6-fold, respectively, over basal levels, while
the full-length genome activated AP-1 by 4.6-fold (Fig.
10A, Table 1). Thus, similar to the observation for NF-B
activation, it appears that in HeLa cells, AP-1 activities
are mediated mainly by both core and NS5A proteins,
while structural proteins could inhibit core-mediated
AP-1 activities.
We next sought to determine the effects of HCV pro-
teins on the MCP-1 promoter in HeLa cells, using the
FIG. 10. Effect of various HCV proteins on the activities of AP-1 and minimal MCP-1 promoter reporter constructs. Luciferase assays were performed
with extracts of HeLa cells (A and B) and Huh7 (C and D) cells cotransfected with reporter constructs for AP-1 (A and C) or MCP-1 promoter,
phMCP128 (B and D), and the various expression constructs for HCV proteins, at 35 h posttransfection. Transfection was performed with the empty
vector, pXJ41neo, to determine basal luciferase levels. SP, NSP, and FL HCV denote expression constructs for HCV structural proteins, nonstructural
proteins, and full-length HCV genome, respectively. Results are expressed as the absolute luciferase activity in each cell extract and were normalized
according to total protein content. Data shown are the means (SD) of three to five independent transfection experiments.
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minimal construct, phMCP128. Akin to the results ob-
tained with the RANTES reporter construct, HCV core
increased MCP-1 promoter activity by 4.3-fold over basal
levels (Fig. 10B, Table 1), while the SP construct in-
creased its activity to a lesser extent (2.5-fold; Fig. 10B,
Table 1). The constructs for NS5A, NSP, and full-length
HCV genome increased the activity of the AP-1 luciferase
reporter construct to comparable levels of 3.0-, 3.5-, and
3.5-fold, respectively. Thus it appears that in HeLa cells,
core and NS5A are mainly responsible for activating
MCP-1 gene and other nonstructural proteins do not
activate MCP-1.
The transfection experiments with the reporter con-
structs for AP-1 and the MCP-1 promoter were then
repeated in the human hepatoma cell line, Huh7. As was
observed with the NF-B and RANTES minimal promoter
constructs, core significantly decreased AP-1 activities in
Huh7 cells. Its binding activities were reduced by 80%
over the basal levels (Fig. 10C, Table 1). The SP construct
likewise did not significantly induce AP-1 promoter ac-
tivity (Fig. 10C, Table 1). Rather NS5A, NSP, and full-
length HCV genome constructs increased the activity of
the AP-1 reporter construct to similar levels, by 2.3-, 3.5-,
and 4.2-fold, respectively, over basal levels. Transfection
experiments with the minimal MCP-1 promoter construct,
phMCP128, in Huh7 cells revealed that core likewise
suppressed its activity. In the presence of core, the
luciferase activities were 62% less than the basal levels
(Fig. 10D, Table 1). Similar to the results obtained in HeLa
cells, the SP construct weakly induced MCP-1 promoter
activity by 2.4-fold (Fig. 10D, Table 1). On the other hand,
NS5A, NSP, and full-length HCV genome constructs in-
creased its activity by 2.5-, 4.5-, and 3.8-fold, respectively.
Thus, in summary, in Huh7 cells, induction of AP-1 and
MCP-1 promoter activities parallels the profile observed
with NF-B and RANTES promoter. Promoter induction in
this context is not mediated by core, but by NS5A. In
addition, in Huh7 cells, E1 and E2 may also activate
MCP-1 via an AP-1 independent mechanism.
Expression of HCV core and NS5A proteins following
transfection in HeLa and Huh7 cells
Our luciferase reporter studies indicated that HCV
core has different effects on gene regulation in the two
cell lines, HeLa and Huh7. HCV core has been shown to
exist in several different isoforms, with sizes of 21, 19
(Hussy et al., 1996; Lo et al., 1995), or 16 kDa (Lo et al.,
1995). Moreover, the p16 isoform has been reported to be
localized to the nucleus, while the larger forms are found
in the cytoplasm (Watashi et al., 2001; Lo et al., 1995;
Suzuki et al., 1995). Retention of core in the cytoplasm is
also believed to be necessary for its ability to activate
NF-B (Watashi et al., 2001). To investigate if the differ-
ence in core-mediated NF-B and AP-1 activities ob-
served in HeLa and Huh7 cells were due to different
processing of the core protein, we first performed West-
ern analyses on these cell lines transfected with expres-
sion constructs for either core, SP, or full-length HCV. To
this end, we used lysates obtained from our previous
transfection experiments with the phR181 construct.
Core activated phR181 only in HeLa cells and not in Huh7
cells (Fig. 9). Two bands with molecular weights of about
17 and 16 kDa were detected in both cell lines trans-
fected with core, SP, or full-length HCV genome, using
anticore-specific antibodies (Figs. 11A and 11B, lanes
2–4). No signal was detected in cell lysates from vector-
transfected cells, used as a control (Figs. 11A and 11B,
lane 1). Thus the difference in core-mediated gene reg-
ulation is not due to different processing of the core in
HeLa and Huh7 cells. As a control, we also examined the
expression of NS5A in these two cell lines. A major band
of about 58 kDa was observed in lysates of cells trans-
fected with constructs expressing NS5A, NSP, and full-
length HCV genome (Figs. 11C and 11D). We next exam-
ined the localization of the core protein in these two cell
lines. HeLa and Huh7 cells were transfected with ex-
pression constructs for core, SP, and full-length HCV
genome and indirect immunofluorescence was per-
formed using anticore antibodies. In all cases, strong
staining was observed in the cytoplasm (Figs. 12A and
12B). Control cells transfected with an empty vector
alone failed to give any staining (Fig. 12). Nevertheless,
there was a difference in the staining pattern observed
between HeLa and Huh7 cells. In the former, the staining
was relatively even and diffused throughout the cyto-
plasm (Fig. 12A), while in the latter, strong staining con-
centrated at the perinuclear regions was observed (Fig.
12B), suggesting that core protein was mainly localized
in the endoplasmic reticulum.
HCV up-regulates the expression of AP-1 mRNA
We observed that HCV up-regulated AP-1 protein bind-
ing activities (Fig. 13). We therefore sought to determine
if HCV could induce the expression of members of the
AP-1 family at the transcriptional level. To do this, we
carried out RT-PCR using primers specific for c-jun with
total cellular RNA from cells transfected with pXJ(S1). We
used RNA obtained from cells transfected with the vector
pXJ41neo as our control. We observed that c-jun tran-
scripts were induced in HeLa, Huh7, and HepG2 2 days
posttransfection with FL HCV (Fig. 13A). Interestingly, at
day 3 posttransfection, its levels were sustained in HeLa
cells but had already begun to decline in the two hepa-
toma cell lines. To further ascertain that HCV indeed
induced the expression of AP-1 transcripts, we per-
formed a semiquantitative PCR for AP-1 using serial
dilutions of the cDNA samples obtained from HepG2
cells. The results indicated that HCV-mediated induction
of AP-1 transcripts was associated with a small increase
of twofold over basal levels (Fig. 13B). These results
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showed that FL HCV could enhance the activity of AP-1
at two levels: the first by inducing the expression of its
transcripts, and the second by increasing its binding
activities to promoter sequences.
DISCUSSION
HCV causes persistent infection, chronic hepatitis in
most infected individuals, which eventually progresses
to cirrhosis and hepatocellular carcinoma (HCC). Spon-
taneous recovery following HCV infection is a relatively
rare event. Although CD4 and CD8 positive T lympho-
cytes are believed to be important in viral clearance
during the acute phase of viral infection (Koziel, 1997;
Pape et al., 1999; Gruner et al., 2000), they are also
involved in the pathogenesis of infection (Jin et al., 1997;
Liaw et al., 1995; Tsai et al., 1997; reviewed in Koziel,
FIG. 11. (A and B) Expression of HCV core proteins in HeLa (A) and Huh7 (B) cells transiently cotransfected with phR181 and vector (lane 1), core
(lane 2), structural proteins (SP, lane 3), and full-length (FL) HCV (lane 4) expression constructs. Cells were harvested at 35 h posttransfection. Cell
lysates were subjected to luciferase assay (Fig. 9) and cell pellets for Western analyses. Pellets were denatured in 1 SDS–loading buffer and
resolved on 12% SDS–PAGE gels and subjected to immunoblot analyses with rabbit polyclonal anticore antibodies as described under Materials and
Methods. (C and D) Expression of HCV NS5A proteins in HeLa (C) and Huh7 (D) cells transiently cotransfected with phR181 and vector (lane 1), NS5A
(lane 2), nonstructural proteins (NSP, lane 3), and full-length (FL) HCV (lane 4) expression constructs. Cells were harvested at 35 h posttransfection.
Cell lysates were subjected to luciferase assay (Fig. 9) and cell pellets for Western analyses for NS5A as described in A and B. Arrows indicate the
respective HCV proteins. Molecular masses in kilodaltons (kDa) of protein molecular weight markers are indicated on the left. Levels of HCV protein
expressed were normalized against endogenous actin levels. A shorter exposure (exp.) of the Western blots of (A) and (B) and a longer of exposure
of (C) and (D) are also shown.
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1997; Tsai and Huang, 1997). Moreover, chronic hepatitis
C infection is characterized by the presence of a large
number of lymphocytes in the inflamed liver (Grabowska
et al., 2001; reviewed in Valiante et al., 2000), which are
implicated in liver damage during infection and as well in
control of viral replication. These cells are clonotypically
different from those of the periphery, suggesting specific
compartmentalization of particular CD4 T cell subsets
FIG. 12. Indirect immunofluorescence staining of HCV core proteins in HeLa (A) and Huh7 (B) cells transiently cotransfected with vector, or
expression constructs for core, structural proteins (SP), and full-length (FL) HCV. Cells were harvested at 35 h posttransfection, permeabilized with
0.1% saponin, and immunostained as described under Materials and Methods. Cells are labeled with anticore antibody, 515S (bottom panels), or
secondary antibody alone (top panels). Control vector-transfected cells gave little background staining, while core-expressing cells showed strong
cytoplasm staining in HeLa cells (A) or perinuclear staining in Huh7 cells (B). Experiments repeated by permeabilization with 0.2% Triton X-100 gave
similar results (data not shown).
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in the liver (Minutello et al., 1993). As was the case with
hepatitis B virus (Kakimi et al., 2001), migration to and
preferential sequestration of CD4 and CD8 T cells in
the HCV-infected liver is likely associated with the che-
mokines. In this study, we show that HCV up-regulates
the expression of two CC chemokines, MCP-1 and RAN-
TES. In both nonhepatic and hepatic cells, induction of
transcripts for both genes was observed as early as 2
days posttransfection with a FL HCV genome (Fig. 2).
Induction of transcripts led to increased production of
these proteins (Fig. 3).
Further investigation revealed that the promoter activ-
ities of both MCP-1 and RANTES were enhanced by
full-length HCV genome expression. Our transfection ex-
periments showed that a 128-nt sequence immediately
upstream of the translational start site of the hMCP-1
promoter (Shyy et al., 1993; Li and Kolattukudy, 1994; Lim
and Garzino-Demo, 2000) was sufficient to give optimal
HCV-mediated gene activity in transfected HeLa and
Huh7 cells (Figs. 4A and 4B). We determined from EM-
SAs that transfection of full-length HCV genome specif-
ically induced the binding of AP-1 activities to the 128-nt
promoter sequence (nt 122), in Huh7 cells, while SP-1
(nt 115) and NF-1 (nt 70) binding activities were re-
sponsible for its constitutive expression (Fig. 5). Super-
shifts performed with SP-1 and AP-1 antibodies confirm
this finding (Fig. 5). The activity of an MCP-1 promoter
construct with additional upstream sequences (nt 129–
213) was only marginally increased as compared to the
128-nt promoter sequence in the presence of HCV (Figs.
4A and 4B). Thus, it appeared that the upstream AP-1 and
NF-B site at nt 150 and 137, respectively, did not
play a significant role in HCV-mediated activation of
hMCP-1. This modality of activation differs from that
which we characterized in HIV-1 Tat-mediated up-regu-
lation of hMCP-1 (Lim and Garzino-Demo, 2000), where
SP-1, AP-1, as well as NF-B activities were involved, but
instead is similar to the reported activation of hMCP-1 by
FIG. 13. (A) RT-PCR of c-jun transcripts in (i) HeLa, (ii) HepG2, and (iii) Huh7 cells transfected with pXJ(S1) at 2 (lane 2) and 3 (lane 3) days
posttransfection. As a control, cells were transfected with vector pXJ41neo for 2 days (lane 1). RT-PCR was performed on total cellular RNA extracted
from cells as described under Materials and Methods. Levels of endogenous actin mRNA (lanes 4–6) were used for normalization. (B) Semiquan-
titative detection of c-jun mRNA in HepG2 cells by RT-PCR. Cells were transfected with pXJ(S1) for 2 (lanes 2, 5, 8, 11, and 14) and 3 days (lanes 3,
6, 9, 12, and 15) or with vector pXJ41neo for 2 days (lanes 1, 4, 7, 10, and 13). Serial dilutions of cDNA samples (1:2, 1:4, 1:8, and 1:16, depicted as
2, 4, 8, and 16) were prepared and subjected to PCR as in (A). Levels of endogenous actin mRNA (iii) are shown.
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TPA, in which only the AP-1-binding elements were im-
portant for its activation (Shyy et al., 1993; Li and Kolat-
tukudy, 1994).
In transfection studies performed with RANTES dele-
tion constructs, a 181-nt sequence immediately upstream
of the translational start site of the RANTES promoter
(Nelson et al., 1993, 1996) was sufficient to give maximal
HCV-mediated gene activity in transfected HeLa and
Huh7 cells (Figs. 4C and 4D). This level of activation is
comparable to those in studies carried out in the T
lymphoma cell line, Hut78 (Nelson et al., 1993), in PHA-
activated PBLs (Nelson et al., 1996), and dengue-infected
cells (Lin et al., 2000). Although three AP-1 sites (402,
420, 429) are located within the RANTES promoter
region (Nelson et al., 1993), our studies indicated that
they did not play a role in HCV-mediated induction of
RANTES. We determined from EMSAs performed with
extracts from Huh7 cells that factors binding to the A/B
site in this region were mainly responsible for mediating
basal RANTES promoter activity (Fig. 7). HCV further
augmented the binding of these factors at this sequence
(Fig. 7). Interestingly, we observed that NF-B was in-
volved in the basal expression of RANTES through bind-
ing at A/B site, and HCV increased its binding to this
element (Fig. 7). Nevertheless, binding of other unknown
factors also appeared to be enhanced. Recently, dengue-
virus 2 was also shown to up-regulate RANTES promoter
activity through binding of NF-IL6 and undefined factor(s)
at regions E and A/B, respectively, in hRAN181 (Lin et al.,
2000). However, we failed to observe any HCV-mediated
increase in the binding of NF-IL6 to hRAN181 (which
suggests a different regulation of the RANTES promoter
by Dengue-virus 2 and HCV), although we found that
NF-IL6 was involved in mediating basal RANTES expres-
sion (Fig. 6). The identity of the HCV-induced A/B binding
factor is currently being investigated.
Thus although the full-length HCV genome we have
constructed was capable of inducing NF-B and AP-1
activities to similar extents (Fig. 8), these factors partic-
ipate to different degrees in the activation of different CC
chemokine genes. The reason for this phenomenon is
unknown, but may be due to a difference in the affinity of
AP-1 and NF-B for their respective binding elements on
the MCP-1 and RANTES promoters to their ability to
cooperate with adjacent binding factors on these pro-
moters or to cell type-specificity.
Several groups have reported that AP-1 activities are
induced by the HCV core (Shrivastava et al., 1998; Kato et
al., 2000) and NS5A (Polyak et al., 2001). Similarly, induc-
tion of NF-B-binding activities by HCV core (Shrivastava
et al., 1998; Marusawa et al., 1999; Kato et al., 2000; Tai
et al., 2000; Watashi et al., 2001; Yoshida et al., 2001) and
NS5A (Gong et al., 2001; Polyak et al., 2001) proteins have
also been described. Nevertheless, it remains possible
that other viral proteins are involved either directly or
indirectly. Our experiments indicated that NS5A was able
to activate both AP-1 and NF-B activities in HeLa and
Huh7 cells (Figs. 9 and 10, Table 1). Similarly, it activates
both MCP-1 and RANTES promoter sequences in these
two cell lines. Other nonstructural HCV proteins did not
appear to activate either AP-1 or NF-B, as an expres-
sion construct bearing all the nonstructural proteins was
not significantly more active than the expression con-
struct for NS5A alone. Nevertheless, in Huh7 cells, other
nonstructural protein(s) may be able to activate RANTES
in a NF-B-independent manner (Table 1).
In contrast, HCV core activated AP-1 and NF-B spe-
cifically in HeLa cells (Figs. 9 and 10, Table 1). A strong
suppression of both AP-1 and NF-B activities was ob-
served in Huh7 cells (Figs. 9 and 10, Table 1). Thus, not
surprisingly, core failed to activate the promoter ele-
ments of both MCP-1 and RANTES genes in Huh7 cells
but strongly augmented their binding activities in HeLa
cells (Figs. 9 and 10, Table 1). A similar suppressive
effect of core on AP-1 and NF-B was observed in an-
other hepatoma cell line, HepG2 (data not shown). While
our findings concur with other reports of core-mediated
induction of NF-B activities in HeLa cells (Shrivastava et
al., 1998; Marusawa et al., 1999; Kato et al., 2000; Yoshida
et al., 2001), they appear to contradict the study of You et
al. (1999), who found increased NF-B binding activities
in stable core-expressing HeLa and Huh7 cells. Instead,
our observations are more consistent with those of Shriv-
astava et al. (1998), who reported that core can suppress
the DNA-binding activities of NF-B induced by cytokines
in MCF cells.
It has been reported that truncated core proteins lack-
ing 20 or more amino acids from the C-terminal end
translocate to the nucleus (Suzuki et al., 1995; Lo et al.,
1996; Watashi et al., 2001) and do not activate NF-B
(Watashi et al., 2001). Yet, in our hands, two forms of
processed core with molecular weight of less than 19
kDa were consistently found in the cytoplasm of trans-
fected HeLa and Huh7 when expressed either alone or
together with other HCV structural and nonstructural
proteins (Figs. 11 and 12). At the same time, these iso-
forms of core display different effects on gene regulation
in these two cell types. Nevertheless, core could be
sublocalized to different compartments in the cytoplasm
of HeLa and Huh7 cells. In the former, it appears to be
evenly distributed in the cytoplasm, while in the latter, it
appears to be localized mainly to the perinuclear region
(Fig. 12). Furthermore, a construct bearing all the struc-
tural proteins persistently failed to activate AP-1 and
NF-B in both HeLa and Huh7 cells (Table 1), suggesting
that E1 and E2 proteins may interact with core (such as
for viral assembly) and prevent/reduce its ability to acti-
vate the two transcription factors. Indeed in support of
this hypothesis, interaction between E1 and core have
been described (Lo et al., 1996).
From these results, we postulate that following HCV
infection in the liver, NS5A, rather than core, is important
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in mediating intracellular events, such as through the
induction of DNA-binding activities of cellular transcrip-
tional factors such as AP-1 and NF-B. In addition, it is
possible that other HCV nonstructural proteins may also
have gene-regulation properties (Table 1; Kato et al.,
2000). Remarkably, we observed that c-jun transcription
is also enhanced by FL HCV (Fig. 13). Thus it appears
that HCV-mediated up-regulation of AP-1 activities oc-
curs at two levels: during transcription and in posttrans-
lation.
HCV is known to cause not only acute and chronic
liver disease, but also immunological and hematologic
disorders, such as autoantibody production, mixed cryo-
globulinemia, and B cell lymphoproliferation (Killenberg,
2000). Moreover, HCV has also been demonstrated to
infect and replicate in peripheral blood mononuclear
cells (PBMCs) (Gabrielli et al., 1994), which may be re-
sponsible for the various HCV-associated extrahepatic
manifestation. In support of this, both positive and neg-
ative strands of the HCV RNA can be detected in B-,
T-lymphocytes, monocytes, and polymorphonuclear leu-
kocytes (PML) in HCV-positive patients (Crovatto et al.,
2000; Mellor et al., 1998). Our findings here suggest that
HCV may induce the migration of monocytes, dendritic,
NK, and/or T cells into the liver through the induction of
MCP-1 and RANTES production in HCV-infected hepato-
cytes, thus possibly contributing to the infection of PB-
MCs, and extrahepatic manifestations. This hypothetical
model is substantiated by reports that HCV-specific B
cells (Zehender et al., 1997; Sansonno et al., 1998), T
cells (Minutello et al., 1993; Crispe et al., 2000), NK, and
TCR/ cells (Nuti et al., 1998) accumulate in the liver
of infected patients. Moreover, HCV induction of CC
chemokine expression may contribute to Fas-mediated
killing of the infiltrating T cells (Crispe et al., 2000). CD8
T cells have also been reported to disappear following
the acute phase of HCV infection resulting in viral per-
sistence (Lechner et al., 2000). Additionally, induction of
CC chemokine may result in T cell activation intrahepati-
cally (Grabowska et al., 2001), causing liver damage and
possibly hepatocarcinogenesis (Liaw et al., 1995; Jin et
al., 1997; Tsai et al., 1997; Pape et al., 1999; Grabowska et
al., 2001). Understanding the mechanisms of activation of
CC chemokines such as MCP-1 and RANTES by HCV
could provide some insights into better management and
control of HCV-associated diseases.
MATERIALS AND METHODS
Construction of HCV-S1 cDNA clones encoding HCV
5NCR and structural proteins
The region spanning the 5NCR to the end of the p7
(from nt 276 to 2461) was PCR amplified using clones
C and D (Lim et al., 2001) as templates with the primers
H2 and H12 (Lim et al., 2001). The resulting 2.7-kb PCR
product and a 600-bp PCR product comprising the NS2
cDNA (from nt 1 to 346) were used as templates in a
second round of PCR to produce a 3.3-kb DNA fragment.
This PCR product and clone A (comprising nt 341 to
72 of the HCV 5NCR) (Lim et al., 2001) were used as
templates in a third round of PCR to generate clone J (nt
341 to 2461). The PCR conditions were previously de-
scribed (Lim et al., 2001). Clone J was digested with
EcoRI and recloned into pcDNA3.1() from Invitrogen
(Carlsbad, CA) and pXJ41neo (Zheng et al., 1992) to
generate pcDNA3(SP) and pXJ41(SP), respectively.
Construction of HCV-S1 cDNA clones encoding HCV
nonstructural proteins and 3 UTR
The region spanning NS3 to NS5A (from nt 3079 to
7328) was obtained by simultaneous insertion of a
1.844-kb BamHI/BmrI fragment from clone F (Lim et al.,
2001) and a 2.4-kb BmrI/EcoRV fragment from clone G
(Lim et al., 2001), into pKSII (/) (Stratagene, Heidel-
berg, Germany) digested with BamHI and EcoRV. The
resulting clone was digested with XbaI and BsrGI and
inserted with a 0.9-kb XbaI/BsrGI fragment containing
the NS2 ORF from clone E (Lim et al., 2001) to produce
clone K (comprising nt 2428–7328). To obtain the region
spanning nt 7200 to 9268, clones H and I (Lim et al., 2001)
were used as templates in a PCR reaction with primers
H22 and H26 (Lim et al., 2001) to generate clone L.
Clones K and L were double-digested with BclI and
EcoRV and ligated together to generate clone M (com-
prising nt 2428–9268). Clone M was digested with NotI
and XhoI and recloned into pcDNA3.1() and pXJ41neo
to generate pcDNA3(NSP) and pXJ41(NSP), respectively.
Construction of full-length cDNA clones of HCV-S1
Clones J and M were double-digested with CspI and
XbaI and ligated together to generate the full-length HCV
genome of HCV-S1 in pKSII(/) designated pKSII(S1).
To generate the full-length clone in pcDNA3.1(), the
EcoRV/BsrGI fragment from pKSII(S1) was ligated to the
pcDNA3(NSP) digested with the same enzymes. To cre-
ate the full-length clone in pXJ41neo, the same fragment
was cloned into the blunt NotI/BsrGI site in pXJ41(NSP).
These constructs were designated pcDNA3(S1) and
pXJ41(S1), respectively.
Sequence analysis
DNA sequencing on all constructs created was carried
out in the core facility at the Institute of Molecular and
Cell Biology. Used were 200 ng of the double-stranded
templates and 10 ng of primers with the Taq DyeDeoxy
terminator cycle sequencing kit and the automated DNA
sequencer 373 from PE Applied Biosystems (Foster City,
CA).
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Cells and cell culture
The human embryonic kidney cell line, 293, bearing
the large T antigen from SV40 (293T), the human epithe-
loid cervical carcinoma cell line HeLa, and human hep-
atoma cell line, HepG2, were purchased from American
Type Cell Collection. The human hepatoma cell line,
Huh7, was obtained from Japan Health Sciences Foun-
dation (Chou-ku, Osaka). The cells were cultured in Ea-
gles’ MEM containing 2 mM L-glutamine, 1.5 g/L sodium
bicarbonate, 0.1 mM nonessential amino acids, 1 mM
sodium pyruvate, and 10% fetal bovine serum and main-
tained at 37°C in 5% CO2.
Cell transfections
Transfection experiments were performed using Ef-
fectene transfection reagent from Qiagen (Valencia, CA).
Cells (1.5  105) were plated into six-well tissue culture
plates 14–18 h before transfection. One microgram of
plasmid DNA in 150 l EC buffer was mixed with 8 l of
enhancer and the mixture was allowed to stand at room
temperature for 2–5 min. Effectene transfection reagent
(25 l) was added and the mixture was incubated at
room temperature for another 5–10 min. Cells were
washed once with PBS and added with DNA-Effectene
mixture diluted in 2 ml of complete growth medium. The
cultures were incubated at 37°C and 5% CO2 for 4–6 h,
after which the medium was aspirated and the cells
washed again. Added to the cells was 2.5 ml fresh
complete medium and incubation was continued for an-
other 48–120 h, after which cells were harvested for RNA
isolation, Western analyses, or luciferase assays.
RNA extraction
Transfected cells were harvested by trypsin treatment
and washed twice in PBS. The cell pellet was lysed with
1.2 ml of the Trizol reagent from Gibco-BRL (Gaithers-
burg, MD). The mixture stood at room temperature for 5
min; 0.35 ml of chloroform was added, and the mixture
was inverted for 20 s. It was incubated for another 5 min
and centrifuged at 12,000 rpm for 20 min. The upper
phase was transferred to a new Eppendorf tube; 0.8 ml of
isopropanol was added, and the mixture was mixed by
inversion again. The tube was left at room temperature
for 5 min, after which it was spun again at 12,000 rpm for
20 min at 4°C. The RNA pellet was air-dried and resus-
pended with 50 l of DEPC-treated water.
RT-PCR
Primers for RT-PCR to detect MCP-1, RANTES, c-jun,
and actin are listed in Table 2. To detect chemokine
mRNA, 2.5 l of the RNA isolated from transfected cells
was reverse transcribed at 42°C for 30 min using ran-
TABLE 1
Summary of the HCV-Mediated Induction of the Various Reporter Promoter Constructs in the Cell Lines HeLa and Huh7
Folds of increase in HeLa (X) Folds of increase in Huh7 (X)
NF-B phR181 AP-1 phMCP128 NF-B phR181 AP-1 phMCP128
Vector 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Core 11.4 5.2 3.0 4.3 0.4 0.3 0.2 0.4
NS5A 2.6 2.8 2.5 3.0 2.4 2.7 2.3 2.5
SP 0.9 2.0 1.0 2.5 1.6 2.0 1.8 2.0
NSP 2.9 3.9 3.6 3.5 3.2 6.8 3.5 4.5
FL HCV 2.6 5.6 4.6 3.5 3.1 6.8 4.2 3.8
Note. The results are represented as folds of increase of luciferase values over basal levels obtained from cotransfection with empty vector.
TABLE 2
Sequences of RT-PCR Primers
Primers Sequence (5–3) Location
MCP-1 FOR AGTCTCTGCCGCCCTTCTGTG nt 59–81
MCP-1 REV GAATCCTGAACCCACTTCTGCT nt 288–310
RANTES FOR ACGCCTCGCTGTCATCCTCATT nt 44–65
RANTES REV ACTCTCCATCCTAGCTCATCTC nt 291–312
c-jun FOR TTAACAGTGGGTGCCAACTCATGCTAACGC nt 2207–2237
c-jun REV GAGATCGAATGTTAGGTCCATGCAGTTCTTG nt 2583–2552
GAPDH FOR CTGAGAACGGGAAGCTTGTCATCAA nt 288–312
GAPDH REV CGTCTAGCTCAGGGATGACCTTGC nt 774–756
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dom hexanucleotides and 200 U MMLV RT (New En-
gland Biolabs, Inc., Beverly, MA). PCR conditions were as
follows: 95°C for 3 min, followed by 30–40 cycles of 95°C
for 1 min, 50°C for 1 min, 72°C for 1 min, and a final
extension 72°C for 8 min. Amplified products were visu-
alized by ethidium bromide staining in a 3% agarose gel.
Luciferase assays
The plasmid pGL2-Basic was purchased from Pro-
mega (Madison, WI), while pAP1-Luc and pNF-B plas-
mids were obtained from Stratagene. The two deletion
constructs of the human MCP-1 (hMCP-1) promoter,
phMCP213 and phMC128, which covered from nts 213
to 6 and 128 to 6, respectively, were previously
described (Lim and Garzino-Demo, 2000). Those for the
human RANTES promoter, phR961 and phR181, covering
the regions from nt 961 to 6 and 181 to 6, were
also previously described (Nelson et al., 1993, 1996) and
kindly provided by Alan M. Krensky (Stanford University,
CA). Luciferase activity was measured using the dual-
luciferase reporter assay system from Promega. Follow-
ing a 35–48 h incubation period, cells were washed
twice with PBS and lysed with 150 l of reporter lysis
buffer. The lysate was allowed to stand at room temper-
ature for 10–15 min and collected into 1.5 ml Eppendorf
tubes. These were spun for 1 min in a microfuge and 10
l of each lysate was mixed with 100 l buffer and
measured for luciferase activities in a Turner luminom-
eter (Turner Designs, Sunnydale, CA) over an integration
period of 15 s. Values obtained were normalized with the
levels of renilla luciferase in the cell lysates. Less than
20% variation was observed between samples.
Nuclear extracts and electrophoretic mobility shift
assays
Nuclear extracts were prepared from 107 cells as de-
scribed previously (Lim and Garzino-Demo, 2000). Pro-
tein concentration was determined with the bicincho-
ninic acid (BCA) protein assay from Pierce (Rockford, IL)
and determined to be between 3–10 g/ml. The DNA
fragment from 128 to 6 of the hMCP-1 promoter was
excised from the plasmid phMCP128 with NheI and BglII
and that from 181 to 6 of the hRANTES promoter was
excised from the plasmid phRAN181 with XbaI and PstI.
Both DNA fragments were filled in using [-32P]dCTP
(New England Biolabs) and Klenow fragment. Oligonu-
cleotides containing NF-IL6 (nt 164) and A/B site (nt
131 to 103) (Nelson et al., 1996) were annealed and
end-labeled with -32P-ATP and T4 kinase. Mobility shift
electrophoresis assay mixtures contained 0.25 ng of 32P-
labeled DNA fragment or double-stranded oligonucleo-
tides (15,000 cpm), 10 mM HEPES at pH 7.9, 1 mM
dithiothreitol, 1 mM EDTA, 0.5 mMMgCl2, 5% glycerol, 0.5
g poly(dI-dC), 0.1 g sonicated salmon sperm DNA, and
4 g of nuclear extract. The binding reactions were
incubated on ice for 20 min and electrophoresed through
5% native polyacrylamide gels in 25 mM Tris borate/0.5
mM EDTA at 270 V for 2–3 h. The gels were dried down
and exposed to X-ray films for 12–16 h at 70°C. Com-
petition assays were performed with 100-fold molar ex-
cess cold DNA fragments from regions 128 to 6 of
hMCP promoter, and region 181 to 6 of hRANTES
promoter or double-stranded oligonucleotides contain-
ing SP1, AP1, NF-B, NF1 (Lim and Garzino-Demo, 2000),
and NF-IL6 and A/B site (Nelson et al., 1996) binding
elements. Supershifts were performed with by preincu-
bation of nuclear extracts with 200 ng of Sp1, AP-1, p50,
or p65 polyclonal antibodies from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA) for 10 min and preincubating the
reaction mixture as described above.
Western blot analysis
Cell lysates were resolved on a 10 or 12% sodium
dodecyl sulphate (SDS)–polyacrylamide gel, transferred
to a nitrocellulose membrane, blocked with 5% nonfat
skim milk in PBS-T, and reacted with primary antibodies
followed by anti-mouse, anti-rabbit, or anti-human anti-
bodies conjugated with horseradish peroxidase (Sigma,
St. Louis, MO). Membrane-bound antibodies were de-
tected with the SuperSignal west pico chemilumines-
cence substrate kit (Pierce). The E2 (H52) monoclonal
antibody which recognizes a conformation-independent
epitope was a kind gift from Jean Dubuisson (Institut de
Biologie de Lille and Institut Pasteur de Lille, Lille Cedex,
France). The monoclonal antibodies for E1 and NS-3
were purchased from Austral Biologicals (San Ramon,
CA), and Devaron, Inc. (Dayton, NJ), respectively, and
those for NS-4B, and -5A were from Biodesign Interna-
tional (Kennebunk, ME). To detect core and NS5B, sera
from HCV-infected patients were used at dilutions of
1:40–1:100. To screen for sera specific against core and
NS5B, we carried out Western analyses with the patient
sera on 293T cells transiently transfected with expres-
sion constructs of core or NS5B. A total of 15 patient sera
samples was tested, three of which were found to react
to NS5B, and at least six were found to react to core
(data not shown). Rabbit polyclonal anticore antibodies
generated with recombinant core protein (aa 1–140)
were also used for analyses.
Intracellular chemokine staining by flow cytometry
Cells were harvested 2–3 days posttransfection,
washed in PBS, and resuspended at 1  106 cells/ml.
Cells were added with 1 vol of 4% formaldehyde/PBS and
incubated at RT for 20 min, followed by washing in PBS.
The cells were spun down and the pellet resuspended in
0.5 g PE-conjugated mouse anti-human RANTES or
MCP-1 monoclonal antibody (PharMingen, San Diego,
CA) in PBS containing 0.5% saponin, 0.5% bovine serum
albumin, and 0.02% Na azide. Incubation was carried at
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RT for 20 min after which the cells were washed and
analyzed on a Becton–Dickinson FACScalibur flow cy-
tometer (San Jose, CA). Live cells were gated and a total
of 10,000 events was collected per analysis.
Indirect immunofluorescence
Cells grown overnight on coverslips were transfected
for 35 h, fixed in 4% paraformaldehyde, and permeabil-
ized with 0.1% saponin. They were stained with anticore
antibody, 515S (diluted 1:100, a kind gift from Prof. Michi-
nori Kohara, The Tokyo Metropolitan Institute of Medical
Science, Tokyo, Japan) in 2% BSA in PBS, followed by
fluorescence isothiocyanate-conjugated anti-mouse an-
tibody (Sigma). Cells were washed with PBS between
steps. Coverslips were mounted and immunofluores-
cence microscopy analyses performed with a MRC1024
(Bio-Rad) confocal laser scanning system.
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